Results from Longitudinal Outcomes in Youth with Type 2 Diabetes—The TODAY2 Study, a post-intervention follow-up to the TODAY Study, will be presented at 1:45 p.m. Saturday in S-154 (South, Upper Mezzanine Level). TODAY2 Study Chair Philip Zeitler, MD, PhD, previews the session and discusses the study’s significance.
The TODAY2 Study results announced soon
